DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Watanabe M, Hibi T, Mostafa NM. et al.
Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn’s disease.
J Crohns Colitis 2014;
8: 1407-1416
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.